Contents & References of Examining the antibody titer obtained from Newcastle vaccination programs in beef mother herds before the start of HI and ELISA brouch production.
List:
The first chapter: Introduction. 1
1-1- Introduction. 1
1-1-History. 3
1-1-2- Synonymous names. 4
1-1-3- Economic importance. 5
1-1-4- The importance of public health. 5
1-1-5- Epidemiology. 6
1-1-6- Morphology. 7
1-1-7- Chemical compounds. 7
1-1-8- Biological characteristics. 8
1-1-8-1- hemagglutinin activity. 8
1-1-8-2- light aminidase activity 9
1-1-8-3- cell adhesion and hemolysis. 9
1-1-8-4- Virus replication. 10
1-1-8-5- sensitivity to physical and chemical agents. 10
1-1-9- Pathogenicity tests. 11
1-1-9-1- Identification of the virus based on the severity of the virus. 11
1-1-9-2- Heat resistance 12
1-1-9-3- Washing. 12
1-1-9-4- Plate size and shape. 13
1-1-9-5- structure of polypeptides 13
1-1-9-7- binding to lectin. 14
1-1-9-8- genetic swimming. 14
1-1-9-9- molecular criteria for pathogenicity. 15
1-1-10- Laboratory hosts. 16
1-1-11- Transfer. 17
1-1-12- dispersion and spread. 17
1-1-13- Expansion. 19
1-1-14- Diagnosis. 20
1-1-14-1- Clinical symptoms. 20
1-1-14-2- Autopsy findings. 22
1-1-14-3- microscopic waste. 22
1-1-14-3-1- Nervous system. 23
1-1-14-3-2- vascular system. 23
1-1-14-3-3- lymphatic system. 23
1-1-14-3-4- intestinal organ. 23
1-1-14-3-5- respiratory system. 24
1-1-14-3-6- Genital system. 24
1-1-14-3-7- Other organs 24
1-1-15- Safety. 25
1-1-15-1- active safety. 25
1-1-15-3- Local immunity. 26
1-1-15-4- patio safety. 26
1-1-15-5- Immune suppression. 27
1-1-16- Separation methods. 27
1-1-16-1- Monoclonal antibodies. 28
1-1-16-2- Serology. 28
1-1-16-3- laboratory tests of pathogenicity. 28
1-1-16-4- serological tests for Newcastle disease virus antibodies. 29
1-1-16-5- Subtractive diagnosis. 29
1-1-16-5-1- Molecular methods in the diagnosis of Newcastle disease. 30
1-1-17-2- National control policies. 33
Control and prevention at the farm level. 33
1-1-18- Vaccination. 34
1-1-18-1- Historical dimensions of vaccination. 34
1-1-18-2- Vaccination policies. 35
1-1-18-3- Live vaccines. 35
Virus strains: 35
1-1-18-3-1- Use of live vaccines. 36
1-1-18-3-2- Advantages and disadvantages of live vaccines. 37
1-1-18-4- Inactive or killed vaccines. 38
1-1-18-4-1- Methods of producing killed or inactive vaccines. 38
1-1-18-4-2- Advantages and disadvantages of killed or inactive vaccines. 38
1-1-18-5- Vaccination program. 39
1-1-18-6- Interpretation of vaccine responses. 39
1-1-18-7- Vaccination of other birds. 40
The second chapter: Research method. 41
2-1- Research method. 41
2-1-1- Vaccination program. 41
2-2-ELISA test 44
2-3-HI test 45
2-3-1- Steps to perform HI test 46
Chapter three: Results. 50
3-1- The results of the comparison of antibody levels in the hemagglutination inhibition test in different groups. 50
3-2- The results of the comparison of antibody levels in the ELISA test in different groups. 51
3-3 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test: 53
3-4 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in form one: 54
3-5 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in Form Two: 55
3-6 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in form three: 56
3-7 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in form four: 57
3-8 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in Form Five: 58
3-9 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test51
3-3 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test: 53
3-4 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in form one: 54
3-5 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in Form two: 55
3-6 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in form three: 56
3-7 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in form four: 57
3-8 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and ELISA test in form five: 58
3-9 Determining the relationship between the antibody titer from the hemagglutination inhibition test and ELISA test in form six: 59
3-10 Determining the relationship between the antibody titer from the hemagglutination inhibition test and the ELISA test in form seven: 60
3-11 Determining the relationship between the antibody titer from the inhibition test From hemagglutination and ELISA test in form eight: 61
3-12 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in form nine: 62
3-12 Determining the relationship between the antibody titer resulting from the hemagglutination inhibition test and the ELISA test in form ten: 63
Chapter four: discussion and conclusion. 64
Chapter Five: Suggestions. 67
List of sources: 68
Persian sources: 68
Latin sources: 68
English summary: 72
Source:
Persian sources:
Rasoulnejad Fereydoni, Sasan., 1370, prevention of reactions The increase caused by the vaccine (translation), Chekauk magazine, number 5, pages 65 to 72. Rasul-nejad Fereydoni, Sasan, 1370, principles of vaccination programs (translation). Chekauk magazine, number 7, pages 35-52. Faizi, Adel, Bijanzad, Peyman, 1389, investigating the effect of Thymus vulgaris volatile oils on growth performance of broiler chickens, number 12, year 14, pages 39-45. Latin sources: Ref: Abdu, 4 P. A., Wakawa, A. M., Sa'idu, L., Joanis, T. M. and Fatihu, M. Y. (2008): A Severe Form of Newcastle Disease Caused by a Mesogenic Virus in Five-Week Old Broilers in Zaria. Vet. Clin. Practice Bull.(1): 1-6.
- 5Adair, B. M., Mcnulty, M. S., Todd, D., Connor, T. J. and Burns, K. (1989): Quantitative Estimation of Newcastle Disease Virus Antibody Levels in Chickens and Turkeys by Elisa. Avian Pathology 18(1): 175 - 192.
- 6 Al-Garib, S. O., Gielkens, A. L. J., Gruys, E. and Kochi, G. (2003): Review of Newcastle Disease Virus with Particular References to Immunity and Vaccination. World's Poultry Science Journal 59(02): 185-200.
- 7Aldous, E. W., Mynn, J. K., Banks, J. and Alexander, D. J. (2003): A Molecular Epidemiological Study of Avian Paramyxovirus Type 1 (Newcastle Disease Virus) Isolates by Phylogenetic Analysis of a Partial Nucleotide Sequence of the Fusion Protein Gene. Avian Pathology 32(3): 239 - 257.
- 8Alexander, D. J. (2000): Newcastle Disease in Ostriches "Struthio Camelus" — a Review. Avian Pathology 29(2): 95 - 100.
- 9Alexander, D. J. (2001): Newcastle Disease. British Poultry Science 42(1): 5 - 22.
- 10Alexander, D. J., Manvell, R. J., Kemp, P. A., Parsons, G., Collins, M. S., Brockman, S., Russell, P. H. and Lister, S. A. (1987): Use of Monoclonal Antibodies in the Characterization of Avian Paramyxovirus Type 1 (Newcastle Disease Virus) Isolates. Submitted to an International Reference Laboratory. Avian Pathology 16(4): 553 - 565.
- 11Alexander, D. J., Senne, D. A., Gough, R. E. and Jones, R. C. (2008). Newcastle Disease, Pneumovirus Infection and Other Paramyxoviruses. Diseases of Poultry. Y. M. Saif. Iowa, IA, Wiley-Blackwell Publishing: 75-115.
- 12Allan, W. H. and Borland, L. J. (1979): The Stress Index: A Method for Indicating the Pathogenicity of Vaccinal Newcastle Disease Virus When Administered by Aerosol. Avian Pathology 8(4): 401 - 409.
- 13Aziz, T. a. G. and Ahmed, T. A. (2010): Serological Survey of Newcastle Disease in Domestic Chickens in Sulaimani Province. Journal of Zankoy Sulaimani 13(1): 31-38.
- 14Beard, C. W. and Wilkes, W. J. (1985): A Comparison of Newcastle Disease Hemagglutination-Inhibition Test Results from Diagnostic Laboratories in the Southeastern United States. Avian Dis 29(4): 1048-1056.
- 15Beard, P. D., Spalatin, J. and Hanson, R. P. (1970): Strain Identification of Newcastle Disease Virus in Tissue Culture. Avian Dis 14(4): 636-645.
- 16Bennejean, G., Guittet, M., Picault, J. P., Bouguet, J. F., Devaux, B., Gaudry, D. and Moreau (1978): Vaccination of One Day-Old Chick against Newcastle Disease Using Inactivated Oil Adjuvant Vaccine and/or Live Vaccine. Avian Pathology 7(1): 13-27.